BPA Call W9114F12A0022-0019

This is a BPA call issued by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment. The BPA, which is under Roche's existing GSA Schedule contract for in vitro diagnostics, covers the exercise of Option Year 1 from December 31, 2016 through December 30, 2017, with a ceiling value of $109,084.80. Roche has provided critical care analyzers, reagents, test kits, and associated equipment...

This is a BPA (Blanket Purchase Agreement) call awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of blood tests. The total ceiling value of this BPA call is $1,968,426.31, with a performance period through March 31, 2026. This award is not set-aside and is placed against Roche's existing GSA Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). Roche Diagnostics is a manufacturer and...

This is a Blanket Purchase Agreement (BPA) call contract awarded to Roche Diagnostics Corporation by the U.S. Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base. The contract is for the provision of Roche's immunoreagents and consumables, which are critical laboratory supplies used in clinical chemistry and immunochemistry analysis. The contract does not have a set-aside designation and has a ceiling value of $284,868.20. Roche Diagnostics is the prime...

Roche Diagnostics Corporation was awarded a Blanket Purchase Agreement (BPA) call valued at $6,905.06 for blanket account reagents for Ventana equipment. This contract was executed on September 21, 2015, with an ultimate completion date of November 30, 2015. The award is a Firm Fixed Price contract with no set-aside designation, meaning it was competed openly in the federal marketplace. Performance of this contract is to be completed in Castleton, Indiana. This award represents a call against...

This is a Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a leading manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated medical products and services. The contract is for REAGENTS AND SUPPLIES with a ceiling value of $59,787.69 and an ultimate completion date of September 30, 2019. This BPA call is part of a larger $37 million BPA with DHA for immunochemistry and clinical...

This is a Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The contract is against VA Schedule #V797P-7347A for reagents and consumables. The award has a ceiling value of $304,720.87 and a completion date of April 15, 2024. No set-aside was used. This BPA call is part of a larger $7 million BPA previously awarded to Roche Diagnostics by the VA to provide chemistry and...

This is a Firm Fixed Price BPA Call contract awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $300,000.00 contract provides reagents and consumables with a completion date of September 30, 2015. Roche Diagnostics has provided critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to...

This is a Blanket Purchase Agreement (BPA) call awarded by the U.S. Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for Automated Chemical Lab Testing, and does not have a set-aside designation. The total ceiling value of the award is $858,590.03, and the ultimate completion date is August 11, 2017. Roche Diagnostics has provided...

<p>The Defense Health Agency issued a BPA call to Roche Diagnostics Corporation on March 12, 2026, for reagents needed for testing, with a ceiling value of $14,915.03 and an ultimate completion date of September 30, 2026. Work will be performed at Castleton, Indiana. The call is priced on a firm fixed-price basis and carries no set-aside designation.</p>

This is a firm-fixed price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the procurement of KAPA reagent kits. The contract has a ceiling value of $11,470.00 and a period of performance through September 30, 2025. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, reagents, and laboratory equipment, has provided similar products and services to various...